S&P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider of post-trade solutions for the global OTC market, to investment funds managed by KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, subject to customary […]
Medication non-adherence is a significant and preventable challenge in healthcare, contributing to an estimated 15% of all healthcare spending, or up to $300 billion annually. Patients skipping doses or abandoning treatments don't just face worse health outcomes – they drive avoidable hospitalizations, complications, and increased costs for the healthcare ecosystem. https://mma.prnewswire.com/media/2242201/Sidekick_Health_Logo.jpg We're making medication adherence
hyperCORE International is pleased to welcome Atlas Clinical Research, based in Durham, North Carolina, to its partner site network, as the clinical research organization continues to expand its global reach and capabilities through alliance partnerships. Atlas strengthens hyperCORE's network with proven expertise in accelerating trials and expanding patient access. Atlas Clinical Research is a therapeutically
Conference call to be held on Monday, April 28, 2025, at 8:30 a.m. Eastern Time InMode Ltd. (Nasdaq:INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2025 before the Nasdaq market opens onMonday, April 28, 2025. https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg InMode is currently finalizing
Chairman and CEO Ian Jenks to Give Presentation on May 14th at the SID Business Conference Smartkem (NASDAQ: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, announced it will exhibit and its CEO will give a presentation at Display Week 2025 taking place at the San
Bio-Thera SolutionsInc.(688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will have an oral presentation in collaboration with medical centers at the 2025 ASCO Annual Meeting entitled “Safety and efficacy of BAT8006, a Folate Receptor a (FRa) antibody drug conjugate (ADC), in patients with platinum-resistant ovarian cancer: Update on the dose
It is our pleasure to announce that the Shanghai Patent Court has ruled in our favor on 10 of 14 points in our Microsoft patent infringement trial. The March 31, 2025, judicial ruling grants us the ability to directly appeal our case to the People's Supreme Court before the statutory timeframe and allowing us to
Thompson Thrift, a full-service nationally recognized real estate company and one of the nation's leading multifamily developers, hosted a ribbon cutting for The Quinn, a 324-unit Class A multifamily community in Pensacola, on Thursday, April 10. The first residents began moving in last fall, and the company expects to complete construction at the end of
Great HealthWorks is proud to be Certified™ by Great Place to Work® for the first time. The prestigious award is based entirely on what current employees say about their experience working at Great HealthWorks. This year, 87% of employees said it's a great place to work – 30% higher than the average U.S. company, with
Lender Compliance Technologies (LCT) today announced its partnership with Proteris Compliance Solutions to provide finance companies in the automotive, marine and powersport industries with seamless access to LCT's advanced lender-managed technologies and Proteris' innovative form approval services. The strategic collaboration will allow lenders and finance companies to stay ahead of the ever-changing regulatory environment through